MAPS (Multidisciplinary Association for Psychedelic Studies) Archives • Psychedelic Chronicle

MAPS (Multidisciplinary Association for Psychedelic Studies)

MAPS is a non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana.

MAPS was founded in 1986 by Rick Doblin, who earned his doctorate in Public Policy from Harvard University's Kennedy School of Government. MAPS' work is based on the belief that psychedelics and marijuana have great therapeutic potential, and that their risks can be minimized through careful research, education, and harm reduction.

MAPS envisions a world where these substances are available for therapeutic use under medical supervision, and where research is conducted openly in order to learn about their risks and benefits. In addition to its own research projects, MAPS also supports other scientists and organizations working on psychedelics and marijuana.

MAPS' mission is to assist society in creating an environment that allows responsible use of psychedelics and marijuana by:

- Funding scientific research into their risks and benefits

- Providing education about their risks and benefits

- Working to change laws that restrict their responsible use

- Supporting harm reduction efforts

MAPS is a 501(c)(3) non-profit organization. All donations are tax-deductible in the United States.

Psychedelic News

MAPS Launches New Online Education Curriculum ‘Psychedelic Fundamentals’

The first part in the new MAPS Digital Learning initiative is Psychedelic Fundamentals, which introduces those interested in learning to the fundamental

July 15, 2022

MAPS (Multidisciplinary Association for Psychedelic Studies)

MAPS Launches New Online Education Curriculum ‘Psychedelic Fundamentals’

Choose Ketamine Complete Capital Raise to Expand Technology Platform

Biomind Labs Secure FDA Pre-IND Meeting for Feedback on NCE Triptax

Silo Pharma Initiate Toxicity Study of Ketamine Formulation for Fibromyalgia Treatment

Suggestions

MAPS (Multidisciplinary Association for Psychedelic Studies)

MAPS Launches New Online Education Curriculum ‘Psychedelic Fundamentals’

Choose Ketamine Complete Capital Raise to Expand Technology Platform

Biomind Labs Secure FDA Pre-IND Meeting for Feedback on NCE Triptax

Silo Pharma Initiate Toxicity Study of Ketamine Formulation for Fibromyalgia Treatment